Biological evaluation of halogenated thioureas as cholinesterases inhibitors against alzheimer's disease & molecular modeling studies

Letters in Drug Design and Discovery

Volumn 12, Issue 6, 2015, Pages 488-494

  Iqbal, Jamshed ^a   Zaib, Sumera ^a   Saeed, Aamer ^b   Muddassar, Muhammad ^c  

^a Tobe Camp University Road Abbottabad   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c Department of Electrical Computer Engineering   (Pakistan)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Docking simulations; Halogenated thioureas; Homology models

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; THIOUREA DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CHOLINESTERASE INHIBITION; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING SITE; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; IN VITRO STUDY; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL;

EID: 84931265540     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/1570180812666141201222247     Document Type: Article

References (40)

1. Francis, P.T.; Palmer, A.M.; Snape, M.; Wilcock, G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress.J. Neurol. Neurosurg. Psychiatry., 1999, 66 (2), 137-47.
2. Bosboom, J.L.; Stoffers, D.; Wolters, E. The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease.J. Neural. Transm. Suppl., 2003, 65, 185-95.
3. Araujo, J.A.; Studzinski, C.M.; Milgram, N.W. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Prog. Neuro-psychopharmacol. Biol. Psychiatry., 2005, 29 (3), 411-22.
4. Sarter, M.; Parikh, V. Choline transporters, cholinergic transmission and cognition. Nat. Rev. Neurosci., 2005, 6 (1), 48-56.
5. Schliebs, R.; Arendt, T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J. Neural. Transm., (Vienna, Austria : 1996) 2006, 113 (11), 1625-44.
6. Shen, Y.; Zhang, J.; Sheng, R.; Dong, X.; He, Q.; Yang, B.; Hu, Y. Synthesis and biological evaluation of novel flavonoid derivatives as dual binding acetylcholinesterase inhibitors. J. Enzyme Inhib. Med. Chem., 2009, 24 (2), 372-80.
7. Zelik, P.; Lukesova, A.; Voloshko, L.N.; Stys, D.; Kopecky, J. Screening for acetylcholinesterase inhibitory activity in cyanobacteria of the genus Nostoc. J. Enzyme Inhib. Med. Chem., 2009, 24 (2), 531-6.
8. Mesulam, M.; Guillozet, A.; Shaw, P.; Quinn, B. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol. Dis., 2002, 9 (1), 88-93.
9. Lane, R.M.; Potkin, S.G.; Enz, A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol., 2006, 9 (1), 101-24.
10. Small, D.H.; Mok, S.S.; Bornstein, J.C. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci., 2001, 2 (8), 595-8.
11. Porcel, J.; Montalban, X. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis. J. Neurol. Sci., 2006, 245 (1-2), 177-81.
12. Hikida, T.; Kitabatake, Y.; Pastan, I.; Nakanishi, S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc. Natl. Acad. Sci. USA., 2003, 100 (10), 6169-73.
13. Bergmann, F.W.I.B.; Nachmansohn, D.T. The inhibitory effect of stilbamidine, curare and related compounds and its relationship to the active groups of acetylcholine esterase; action of stilbamidine upon nerve impulse conduction.Biochim. Biophys. Acta., 1950, 6 (1), 217-24.
14. Austin, L.; Berry, W.K. Two selective inhibitors of cholinesterase. Biochem. J., 1953, 54 (4), 695-700.
15. Davis, K.L.; Powchik, P. Tacrine. Lancet, 1995, 345 (8950), 625-30.
16. Rogers, S.L.; Farlow, M.R.; Doody, R.S.; Mohs, R.; Friedhoff, L. T. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology, 1998, 50 (1), 136-45.
17. Farlow, M.R.; Lilly, M.L. Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years. BMC Geriatr., 2005, 5, 3.
18. Marco-Contelles, J.; do Carmo Carreiras, M.; Rodriguez, C.; Villarroya, M.; Garcia, A. G. Synthesis and pharmacology of galantamine. Chem. Rev., 2006, 106 (1), 116-33.
19. Mali, S.L.V.V.; Pitliya, R.L.; Vaidya, V.K.; Ameta, S.C. Photochemical Oxidation of Dimethyl Sulphoxide by Singlet oxygen. Asian J. Chem., 1994, 6, 796-800.
20. Saeed, A.F.U.; Erben, M.F. A review on the chemistry, coordination, structure and biological properties of 1-(acyl/aroyl)-3- (substituted) thioureas. J. Sulfur Chem., 2013, 1-38.
21. Recanatini, M.; Cavalli, A.; Hansch, C. A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease. Chem. Biol. Interact., 1997, 105 (3), 199-228.
22. Saeed, S.R.N.; Ali, M.; Hussain, R.; Jones, P. Synthesis, spectroscopic characterization, crystal structure and pharmacological properties of some novel thiophene-thiourea core derivatives. Eur. J. Chem., 2010, 1 (3), 221-227.
23. Halim, N.I.M.K.K.; Fadzil, A.H.; Yamin, B.M. Synthesis, characterization and antibacterial studies of benzoylthiourea derivatives. IPCBEE 2011, 14, 55-59.
24. Halim, N.I.M.K., Fadzil, A.H.; Yamin, B.M. Synthesis, characterisation and antibacterial studies of Cu (II) complexes thiourea. Malays. J. Anal. Sci., 2012, 16 (1), 56-61.
25. Karakus, S.; Rollas, S. Synthesis and antituberculosis activity of new N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl] thioureas. Farmaco, (Societa chimica italiana: 1989) 2002, 57 (7), 577-81.
26. Spilovska, K.; Korabecny, J.; Kral, J.; Horova, A.; Musilek, K.; Soukup, O.; Drtinova, L.; Gazova, Z.; Siposova, K.; Kuca, K. 7- Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer's Disease Treatment - Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules,(Basel, Switzerland) 2013, 18 (2), 2397-2418.
27. Ramadas, K.G.S.N.; Janarthanan, S.; Masilamani. Antifungal Activity of 1,3-Disunstituted Symmetrical and Unsymmetrical Thioureas. Pestic. Sci., 1998, 52, 145-51.
28. Sijia, X.D.L.K.; Shaoyong, J.; Liangbin. Synthesis, Crystal structure and herbicidal activity of 1-Benzoyl, 3-(4,6-disubstitutepyrimidine- 2-yl)-Thiourea. Chem. J., 2003, 5 (8), 67-70.
29. Antelo, J.M.C.J.; Leis, J.R.; Ríos, A. Nucleophilic reactivity towards electrophilic fluorinating agents: reaction with Nfluorobenzenesulfonimide ((PhSO2) 2NF). J. Chem. Soc. Perkin Trans., 2, 2000, 2071-2076.
30. Alkorta, I.R.I.; Elguero, J. Effect of fluorine substitution on hydrogen bond interactions. J. Fluorine Chem., 2000, 101, 233-8.
31. Wakefield, B. Fluorinated pharmaceuticals. Innov. Pharm. Technol., 2000, 74-8.
32. Wakselman, C. Fluorinated organic compounds: synthesis and biological applications (In French). Ann. Pharm. Fr., 1999, 57 (2), 108-15.
33. Saeed, A.S.U.; Hameed, A.; Naqvi, S. Synthesis, characterization and antimicrobial activity of some new 1-(fluorobenzoyl)-3- (fluorophenyl) thioureas. J. Fluorine Chem., 2009, 130 (11), 1028-34.
34. Villatte, F.; Marcel, V.; Estrada-Mondaca, S.; Fournier, D. Engineering sensitive acetylcholinesterase for detection of organophosphate and carbamate insecticides. Biosens. Bioelectron., 1998, 13 (2), 157-64.
35. Ligprep, V. 2.3, (2009) Schrodinger. LLC, New York, NY.
36. Raza, R.; Saeed, A.; Arif, M.; Mahmood, S.; Muddassar, M.; Raza, A.; Iqbal, J. Synthesis and biological evaluation of 3- thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors. Chem. Biol. Drug Des., 2012, 80 (4), 605-15.
37. Friesner, R.A.; Banks, J.L.; Murphy, R.B.; Halgren, T.A.; Klicic, J.J.; Mainz, D.T.; Repasky, M.P.; Knoll, E.H.; Shelley, M.; Perry, J.K.; Shaw, D.E.; Francis, P.; Shenkin, P.S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem., 2004, 47 (7), 1739-49.
38. Xiao, M.L.; Chen, F.H.; Chen, Z.J.; Guo, B.S.; Lv, X.H.; Tang, W. M. Facile synthesis of thiourea derivatives in ionic liquid. Chin. Chem. Lett., 2007, 18 (3), 258-260.
39. Ellman, G.L.; Courtney, K.D.; Andres, V. Jr.; Feather-Stone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. pharmacol., 1961, 7, 88-95.
40. Darvesh, S.; Hopkins, D.A.; Geula, C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci., 2003, 4 (2), 131-8.